newsfilter
← Latest News
GlobeNewswire·

Bioxytran, Inc. Announces the Reinitiation of Coverage of Its Stock by Avise Analytics

BOSTON, MASSACHUSETTS, Nov. 22, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB:BIXT), a clinical stage biotechnology company developing novel therapies targeting the treatment of significant unmet medical needs in